tafinlar
novartis europharm limited - dabrafenib mesilate - Меланомът - Антинеопластични средства - melanomadabrafenib as monotherapy or in combination with trametinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 и 5. Помощните терапия melanomadabrafenib в комбинация с trametinib е показан за адъювантного лечение на възрастни пациенти с iii състояние на меланом с Браф v600 мутация далеч, след пълна резекция на. non-small cell lung cancer (nsclc)dabrafenib in combination with trametinib is indicated for the treatment of adult patients with advanced non-small cell lung cancer with a braf v600 mutation.
candezek combi 16 mg/10 mg capsules, hard
16 mg/10 mg capsules, hard
candezek combi 8 mg/10 mg capsules, hard
8 mg/10 mg capsules, hard
luxfen combi 2 mg/ml + 5 mg/ml eye drops, solution
2 mg/ml + 5 mg/ml eye drops, solution
pernuvi combi 50 mg/1000 mg film - coated tablets
50 mg/1000 mg film - coated tablets
pernuvi combi 50 mg/850 mg film - coated tablets
50 mg/850 mg film - coated tablets
pizona combi 15 mg/850 mg film - coated tablets
15 mg/850 mg film - coated tablets
prestozek combi 4 mg/10 mg tablets
4 mg/10 mg tablets
prestozek combi 8 mg/5 mg tablets
8 mg/5 mg tablets
prestozek combi 8 mg/10 mg tablets
8 mg/10 mg tablets